MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ProQR Therapeutics NV Company Profile (NASDAQ:PRQR)

Consensus Ratings for ProQR Therapeutics NV (NASDAQ:PRQR) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $27.00 (456.70% upside)

Analysts' Ratings History for ProQR Therapeutics NV (NASDAQ:PRQR)
Show:
DateFirmActionRatingPrice TargetActions
3/15/2016JMP SecuritiesLower Price TargetMarket Outperform$24.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016HC WainwrightReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015Leerink SwannReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2014Deutsche BankInitiated CoverageBuy$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Jefferies GroupInitiated CoverageOutperform$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha